NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-095-1991-0-US-05 MONOCLONAL ANTIBODIES DIRECTED TO ACTIVATED ENDOTHELIAL CELLS, MEDICAMENTS AND THERAPEUTIC METHODS EMPLOYING THE MONOCLONAL... US CON 08/180,274 Abandoned
NIDDK E-226-1992-0-EP-09 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex EP National Stage 94906547.8 Abandoned
NIDDK E-226-1992-0-AT-03 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex AT EP 94906547.8 Abandoned
NIDDK E-226-1992-0-BE-05 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex BE EP 94906547.8 Abandoned
NIDDK E-226-1992-0-FR-10 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex FR EP 94906547.8 Abandoned
NIDDK E-226-1992-0-DE-08 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex DE EP 94906547.8 Abandoned
NIDDK E-226-1992-0-IE-12 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex IE EP 94906547.8 Abandoned
NIDDK E-226-1992-0-MC-16 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex MC EP 94906547.8 Abandoned
NIDDK E-226-1992-0-LI-14 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex LI EP 94906547.8 Abandoned
NIDDK E-226-1992-0-LU-15 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex LU EP 94906547.8 Abandoned
NIDDK E-226-1992-0-GB-11 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex GB EP 94906547.8 Abandoned
NIDDK E-226-1992-0-CH-07 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex CH EP 94906547.8 Abandoned
NCI E-187-1990-0-US-07 CELL STRESS TRANSCRIPTIONAL FACTORS US FWC 08/178,477 5756343 Expired PDF
NIDDK E-226-1992-0-AU-04 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex AU National Stage 60228/94 Abandoned
NCI E-130-1993-0-DE-05 METHODS OF DELIVERING AGENTS TO TARGET CELLS DE EP 94907165.8 Abandoned
NCI E-130-1993-0-FR-08 METHODS OF DELIVERING AGENTS TO TARGET CELLS FR EP 94907165.8 Abandoned
NCI E-130-1993-0-ES-07 METHODS OF DELIVERING AGENTS TO TARGET CELLS ES EP 94907165.8 Abandoned
NCI E-130-1993-0-GB-09 METHODS OF DELIVERING AGENTS TO TARGET CELLS GB EP 94907165.8 Abandoned
NCI E-130-1993-0-IT-10 METHODS OF DELIVERING AGENTS TO TARGET CELLS IT EP 94907165.8 Abandoned
NCI E-130-1993-0-EP-06 METHODS OF DELIVERING AGENTS TO TARGET CELLS EP National Stage 94907165.8 Abandoned
NCI E-130-1993-0-AU-03 METHODS OF DELIVERING AGENTS TO TARGET CELLS AU National Stage 60846/94 Abandoned
NCI E-130-1993-0-PCT-02 METHODS OF DELIVERING AGENTS TO TARGET CELLS PCT PCT PCT/US1994/000261 Expired
NIDDK E-226-1992-0-PCT-02 Methods for the Improvement of Cognition with Functionaal Antagonists of the Glycine NMDA Receptor Complex PCT PCT PCT/US94/000235 Abandoned
NIDDK E-226-1992-0-CA-06 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex CA National Stage 2153596 Abandoned
NIDDK E-226-1992-0-JP-13 Methods for the Improvement of Cognition with Functional Antagonists of the Glycine NMDA Receptor Complex JP National Stage 6-516227 Abandoned
NCI E-130-1993-0-JP-11 METHODS OF DELIVERING AGENTS TO TARGET CELLS JP National Stage 516239/94 Abandoned
NCI E-175-1992-0-US-08 TAXOL TREATMENT OF BREAST CANCER US FWC 08/178,463 5496846 Expired PDF
NCI E-317-1984-17-US-01 Cloned DNA Sequences Related To The Genomic RNA Of L;ymphadenopathy-Associated Virus (LAV) And Proteins Encoded By Said LAV Genomic RNA US DIV 08/177,920 Abandoned
NCI E-227-1993-0-US-01 BSK RECEPTOR-LIKE TYROSINE KINASE AND LIGAND AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US ORD 08/177,812 Abandoned
NCI E-276-1988-1-US-21 THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS HUMAN RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA US FWC 08/176,682 5674720 Expired PDF
NIMH E-121-1991-0-US-07 HOST CELL LINE LVIP2.0ZC, USEFUL IN ASSAYS TO IDENTIFY LIGANDS AND ANT AGONISTS OF G PROTEIN-COUPLED RECEPTORS US FWC 08/176,310 5532157 Expired PDF
NIEHS E-015-1993-0-US-01 FLUORESCENT INTRACELLULAR CALCIUM INDICATORS US ORD 08/175,590 5516911 Expired PDF
NIAID E-226-1989-0-US-03 SPECIFIC AND SENSITIVE DIAGNOSTIC TEST FOR LYME DISEASE US FWC 08/173,718 5489511 Expired PDF
NCI E-051-1994-0-US-01 METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40 US ORD 08/172,664 Abandoned
NIAID E-171-1988-1-US-01 Vaccine for Dengue Virus US CIP 08/173,190 Abandoned
NCI E-116-2007-2-US-02 Self Assembled, Defective, Non-self Propagating Lentivirus Particles US CON 07/995,923 5614404 Expired PDF
NCI E-110-1992-0-US-02 1,2-DIHYDROELLIPTICINES WITH ACTIVITY AGAINST CNS SPECIFIC CANCER CELL LINES US DIV 08/171,234 5441941 Expired PDF
NCI E-002-1994-0-US-01 DENDRIMER-CHELATE CONJUGATES AND METAL COMPLEXES FORMED THEREOF US ORD 08/170,937 Abandoned
NIDDK E-130-1992-0-US-01 A Method For The Treatment of Acquired Immunodeficiency Syndrome. US ORD 08/050,370 Abandoned
NICHD E-050-1992-0-US-07 DETOXIFIED LPS-CHOLERA TOXIN CONJUGATE VACCINE FOR PREVENTION OF CHOLERA US FWC 08/171,188 Abandoned
NCI E-157-1993-1-US-01 METHOD OF TREATING HIV IN HUMANS BY ADMINISTRATION OF DDI AND HYDROXYC ARBAMIDE US ORD 08/169,253 5521161 Abandoned PDF
NCI E-241-1993-0-US-01 MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PROTEINS AS THERAPEUTIC AGENTS AND VACCINES IN THE TREATMENT AND PREVENTION OF ... US ORD 08/169,928 Abandoned
NCI E-071-1991-1-US-02 METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER US FWC 08/169,962 Abandoned
NIEHS E-218-1988-0-US-04 SENSITIVE YEAST SYSTEM FOR DETECTION OF ANEUPLOIDY AND IDENTIFICATION OF TARGETS US FWC 07/993,952 Abandoned
NCI E-219-2009-0-US-02 HIV Probes For Use In Solution Phase Sandwich Hybridization Assays US CON 08/169,715 6300056 Expired PDF
NIDCR E-026-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US93/12310 Abandoned
NCI E-017-1991-0-US-03 AZO DYE DERIVATIVES EXHIBITING ANTI-HIV ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR USING THE SAME US CON 08/167,296 Abandoned
NCI E-046-1993-0-PCT-02 EXPRESSION CLONING OF A HUMAN PHOSPHATASE PCT PCT PCT/US1993/012019 Abandoned
NHLBI E-129-1991-0-US-03 Adenovirus Comprising Deletions on The E1A, E1B And E3 Regions For Transfer of Genes to The Lung US FWC 08/165,753 6013638 Expired PDF
NCI E-352-1987-0-US-04 RECOMBINANT VACCINNIA VIRUS ENCODING CYTOCHROMES P-450 US FWC 08/166,287 5506138 Expired PDF